Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

QSIT Inspections To Take Effect By Oct. 1; Pilot Data Released May 5

This article was originally published in The Gray Sheet

Executive Summary

FDA field investigators will be prepared by Oct. 1 to carry out an audit of a firm's conformance to quality system regulations using the agency's recently piloted quality systems inspection technique (QSIT), Center for Devices and Radiological Health Office of Compliance's Christine Nelson announced during a May 5 Food & Drug Law Institute videoconference.

You may also be interested in...



QSIT Survey Results Show Reduction in Management Non-Compliance

FDA remains skeptical about the root cause of the reduction in management-related non-compliance deficiencies reported in recent data on the agency's Quality System Inspection Technique program.

Merz Consumer Care Optimistic About Future As German Lockdown Continues

Will the second wave of coronavirus lockdown have the same impact on the European consumer health industry? Speaking exclusively to HBW Insight from Germany, Merz Consumer Care CEO Frank Baldauf thinks not. Recently investing in premium beard care brand Brooklyn Soap and launching its tetesept Formula range in the Netherlands, Merz's Baldauf suggest that there will be less panic buying this time round and the CHC supply chain will hold up under pressure. 

UsernamePublicRestriction

Register

LL1134531

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel